Olatec Therapeutics, Inc.
8 clinical trials · Sponsor
◉ Watch Olatec Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare (NCT05658575) | Olatec Therapeutics, Inc. | 2023-01-06 |
| Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome (NCT04540120) | Olatec Therapeutics, Inc. | 2020-09-24 |
| Pilot Study of Dapansutrile Capsules in Schnitzler's Syndrome (NCT03595371) | Olatec Therapeutics, Inc. | 2018-05-15 |
Track Olatec Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.